Overcoming Challenges in Long-Range Planning Forecasting | Evaluate
Join our webinar, The Forecaster’s Guide to Long-Range Planning, to uncover key challenges, explore solutions, and gain practical strategies for success.| Evaluate
Join our webinar, The Forecaster’s Guide to Long-Range Planning, to uncover key challenges, explore solutions, and gain practical strategies for success.| Evaluate
In our 2025 Preview webinar our panel discussed the evolution of obesity drugs, the role of China in pharma dealmaking & biotech commercialisation.| Evaluate
Once again, the pharma industry starts a new year with hopes of a recovery. Will 2025 finally see a return of IPOs? Of mega-mergers? Of huge rounds of investment? Perhaps, but more likely this year will simply be a few steps in the right direction. There is still a great deal of uncertainty, particularly around […] The post What Will 2025 Hold for Pharma? appeared first on Evaluate.| Evaluate
Our Voice of the Customer lead, Magda Lis-Podjaska, shares her views on biopharma, CDMO and challenges for biotechs.| Evaluate
Obesity. The Inflation Reduction Act. Orphan Drugs. CDMOs. Successful forecasting techniques. We’ve covered all this and more in our biopharma reports, webinars and analysis throughout 2024. As I’ve had the pleasure of working with our experts to create all this content, I thought year-end was a splendid opportunity to share the most-read pieces of the […] The post Biopharma Reading List: The Evaluate Top 10 of 2024 appeared first on Evaluate.| Evaluate
The relationship between epidemiology forecasting and data sources is a complex one. Generating accurate forecasts relies heavily on data, and factors such as real-world data and artificial intelligence (AI) have an increasing impact. Factors affecting forecast quality and accuracy There are a few factors that contribute to the accuracy of epidemiological forecasts. Firstly, the […] The post Epidemiology forecasting and the impact of data sources on accuracy appeared first on Evaluate.| Evaluate
Access all the crucial insights you need with Competitive Landscape Analysis, facilitating risk assessment, uncovering unmet needs, and gaining deeper insights into your growth drivers and product differentiators. Empower your SEO strategy with these optimized descriptions.| Evaluate
Company Profiling helps you discover, profile, and track the ideal companies aligned with your growth strategy.| Evaluate
Evaluate Commercial Opportunity Assessment integrates company financials, product attributes, consensus forecasts, and market insights to guide your strategic product placement effectively.| Evaluate
Unlock accurate, unbiased, and timely insights into pharmaceutical asset potential through our solutions. Forecast product-level risks, costs, and timelines to empower confident commercial decision-making.| Evaluate
Utilize Evaluate for Market Opportunity Sizing to gain comprehensive insights into the potential clinical and commercial differentiation of new assets, their competitive landscape, and the market dynamics.| Evaluate
Effective forecasting stands as a cornerstone for pharmaceutical and biotechnology enterprises, shaping strategies, mitigating risks, and propelling innovation forward. Elevate your decision-making with Evaluate Pharma, the premier destination for consensus forecasts trusted by pharmaceutical firms, investment banks, and consultancies alike.| Evaluate
Leverage Evaluate's benchmarking and negotiation tools to gain insights into the dealmaking landscape, supported by extensive historical data for context.| Evaluate
